ICPerMed Action Plan for Personalised Medicine published

22 March 2017 – The International Consortium for Personalised Medicine (ICPerMed) identifies future research needs in a common Action Plan. The aim of ICPerMed is to boost personalised medicine by an enhanced coordination and alignment of research activities. Over the past year, the members of ICPerMed have developed a common Action Plan with central research and research-supporting activities in all areas relevant to personalised medicine.

ICPerMed chair Mairead O'Driscoll says: “Personalised medicine is a new approach to healthcare, putting citizens at the centre of innovation. We expect this Action Plan to initiate joint research investments and activities necessary to tackle the complex implementation of personalised medicine.”

Hence it is the first time that such an impressive number of research funders and policy-makers have identified and published a consensus view on the research and development needed in order to further advance personalised medicine.

The Action Plan lists, 22 research and 8 supporting activities, which have been identified as ‘ready for action’. These span the whole healthcare value chain, from basic to clinical research until market access, and also take into account patient empowerment and sustainability of healthcare systems. ICPerMed regards this Action Plan as a blueprint for a coordinated approach for personalised medicine research and the reasonable implementation of innovative and promising approaches in the health systems.

Further information and a full list of ICPerMed members are available on the webpage: www.ICPerMed.eu

For inquiries, please contact the ICPerMed Secretariat:
e-mail: ICPerMed@dlr.de
phone: +49 228-3821-1266